New shingles vaccine is highly effective, long-lasting — and in short supply

A national shortage of a new and more effective vaccine to protect adults over 50 from the painful rash known as shingles is prompting retailers to create waiting lists and the manufacturer to delay additional promotion. Shingrix, licensed in the fall by the Food and Drug Administration, is the preferred vaccine recommended by the Centers […]